The global pain management
therapeutics market is expected to witness a decline during the forecast period
(2012 to 2018) due to patent expirations of the key blockbuster revenue
generating drugs such as Cymbalta (duloxetine) of Eli Lilly & Co. and Lyrica
(pregabalin) of Pfizer, Inc. This report studies the global market for pain
management therapeutics from three perspectives - therapeutic classes of drugs,
indications and geography. Each of these segments is further classified into
sub-segments; therapeutic classes include anticonvulsants, antidepressants,
anesthetics, NSAIDs, opioids, anti-migraine agents and other non-narcotic
analgesics.
To check out the complete table of
contents, visit: http://www.marketresearchreports.biz/analysis-details/pain-management-therapeutics-market-global-industry-size-share-trends-analysis-and-forecast-2012-2018
The various pain management
indications studied in this report include neuropathic pain, fibromyalgia,
arthritic pain, chronic back pain, migraine, post-operative pain and cancer
pain. Market sizes and forecasts for the period 2010 – 2018 have been provided
for each of the segments and sub-segments in terms of USD million, considering
2011 as the base year. The % compound annual growth rate (CAGR) for each market
segment for the forecast period (2012 to 2018) has been provided along with
market size estimations.
To Get More Detail Info. About
Report: http://www.marketresearchreports.biz/sample/sample/166588
Geographically, the market has been
segmented into four regions, namely, North America, Europe, Asia-Pacific and
Rest of the World (RoW). The respective market sizes and forecasts have been
provided for each of these regions along with the CAGR. The market overview
section of the report provides a detailed breakdown of various aspects of
market dynamics such as drivers, restraints and opportunities along with market
attractiveness analysis and Porter’s five force analysis for the pain
management therapeutics market.
To buy the copy of this report,
visit: http://www.marketresearchreports.biz/analysis/166588
The competitive landscape section
includes market share analysis of all the leading players in the branded
pharmaceuticals market for pain management, in terms of percentage share in the
year 2011. Some of the major players profiled in this report include Abbott
Laboratories, Inc., AstraZeneca PLC, Eli Lilly & Co., Endo Health
Solutions, Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc. and
Purdue Pharma LP.
Related Reports:
About Us
MarketResearchReports.Biz is the
most comprehensive collection of market research reports.
MarketResearchReports.Biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Website:
http://www.marketresearchreports.biz/
Blog:
http://mresearchreports.blogspot.com
Blog:
http://chinamarketreports.blogspot.com/
No comments:
Post a Comment